INS and type 2 diabetes mellitus: Furthermore, bromocriptine, a dopamine agonist that is well known to suppress serum PRL levels, has been shown to effectively improve insulin sensitivity, and has been approved for the treatment for type 2 diabetes mellitus in the United Sates [19].